urothelial carcinoma

Immuno-oncology bladder drug wins approvalSoon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.
Atezolizumab for Urothelial Carcinoma and Non-Small Cell Lung CancerHere: an overview of atezolizumab, the first new drug in two decades for bladder cancer and now approved for NSCLC.
Uro Pipeline: Phase III data show drug’s benefit in castrate-resistant PCaOther pipeline products discussed in this article include agents for urinary catheter blockage, prostate cancer, bladder cancer, and overactive bladder.
Smoking linked with worse urothelial Ca prognosisResearchers at UCLA’s Institute of Urologic Oncology and department of urology have classified kidney cancer into several unique subtypes, a finding that could help physicians tailor treatment to individual patients.